Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (4): 394-398    DOI: 10.12891/ceog17392014
Original Research Previous articles | Next articles
Study of Urotensin II gene and serum levels in relation to pre-eclampsia
R.M. ElSharkawy1, F.M. Shawky Moiety2, *(), H.M. Hegab2
1Department of Chemical Pathology, Medical Research Institute, Alexandria University, Aleaxandria
2Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Alexandria (Egypt)
Download:  PDF(98KB)  ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To verify the relationship between Urotensin II (UII) gene and serum levels and pre-eclampsia (PE). Study Design: Prospective case control study. Setting: Tertiary Obstetric centre and university hospital. Subjects: A total of 80 pregnant women at their third trimester were included, 30 of which were with mild PE, 30 with severe disease and 20 age- and BMI-matched normotensive pregnant women (controls). Materials and Methods: UII gene polymorphism as well as UII serum levels were assessed and compared in patients vs. control. Results: No difference was seen between the groups in terms of age or parity at the time of recruitment. A statistically significant difference in the Urotensin II genotype frequencies between patients and control groups was found. The mean serum UII, also showed a significant difference between the studied groups, and control group. Comparing the observed and expected values of UII genotype frequencies in mild, severe PE, and in controls, no significant difference was noted in the homo-mutant, the hetero-mutant or the wild genotypes. Conclusions: Elevation of UII in the serum of PE patients could be correlated to the severity and/or progression of the disease. The UII genotype frequencies between patients and control groups showed a significant difference, which implies a potential benefit for UII gene or level in serum as a diagnostic or prognostic indicator in pre-eclampsia.
Key words:  Pre-eclampsia      Urotensin II     
Published:  10 August 2014     
*Corresponding Author(s):  F.M. SHAWKY MOIETY     E-mail:  fmoiety@gmail.com

Cite this article: 

R.M. ElSharkawy, F.M. Shawky Moiety, H.M. Hegab. Study of Urotensin II gene and serum levels in relation to pre-eclampsia. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(4): 394-398.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog17392014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I4/394

[1] Bao-Juan Yang, Ji-Wei Sun, Qing Zhang, Da-Jun Cai. Postpartum hepatic rupture and intestinal fistula associated with severe pre-eclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 622-625.
[2] Y. Park, Y.J. Moon, J.Y. Kwon, A.L. Kim, Y.H. Kim. The expression of sirtuin1 in normal and preeclamptic villous explants under hypoxia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 75-80.
[3] F.Y. Azizieh, R. Raghupathy. IL-10 and pregnancy complications[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 252-258.
[4] W.1S. Hu, Y. Feng, M. Y. Dong, J. He. Comparing maternal and perinatal outcomes in pregnancies complicated by preeclampsia superimposed chronic hypertension and preeclampsia alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(2): 212-215.
[5] A. Liberis, G. Stanulov, E. Chafouz Ali, A. Hassan, A. Pagalos, E.N. Kontomanolis. Pre-eclampsia and the vascular endothelial growth factor: a new aspect[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 9-13.
[6] S.O. Altinkaya, S. Nergiz, M. Küçük, H. Yüksel, Y. Dayanir. Posterior reversible encephalopathy syndrome in obstetric patients. Report of three cases with literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(6): 730-733.
[7] S. Kalkanli, E. Deveci, M.E. Sak, M.S. Evsen, Ö. Baran, S. Özekinci, D. Yavuz. CD34 expression of chorionic villous in pre-eclamptic placenta: an immunohistochemical and ultrastructural study[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(3): 425-428.
[8] P. Anastasiadis, P. Anninos, N. Koutlaki, A. Kotini, K. Avgidou, A. Adamopoulos. Neonatal magnetoencephalography and spectral analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2001, 28(4): 269-273.
[9] R. D'Anna, A. Scilipoti, J. Leonardi, M. Scuderi, V. M. Jasonni, R. Leonardi. Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation[J]. Clinical and Experimental Obstetrics & Gynecology, 1997, 24(3): 135-137.
No Suggested Reading articles found!